time.com

time.com
Share

time.com

 •  December 29, 2017

U.S. regulators warned Fresenius SE after the company’s Indian plant that makes cancer-drug ingredients for the U.S. market aborted hundreds of drug-quality tests because they seemed like they were going to fail due to impurities. When workers at the plant found potential tainted products, they halted the tests and said human or machine errors were...

time.com

 •  December 21, 2017

TIME Health For more, visit TIME Health. It’s been a good year for gene therapy, after decades of false starts. On Tuesday, the Food and Drug Administration (FDA) approved the first gene therapy to treat an inherited genetic disease. Earlier this year, the agency approved the first gene therapy in the U.S., for the treatment of leukemia in...

time.com

 •  February 14, 2017

The world’s first malaria vaccine may just be a year away, after a thorough trial of a new drug showed promising results. PLOS Medicine on Tuesday published a study, in which researchers found that for every 1,000 children who received the vaccine, 800 cases of illness could be prevented. The children also retained protection 18 months after being...